{"filing":{"accession_number":"0001213900-26-064037","cik":"0001840425","ticker":"OSRHW","company_name":"OSR Holdings, Inc.","form":"8-K","filing_date":"2026-06-02","report_date":null,"primary_document":"ea0293037-8k_osrhold.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1840425/000121390026064037/ea0293037-8k_osrhold.htm"},"events":[{"id":7517,"run_id":6605,"accession_number":"0001213900-26-064037","anchor_item_number":"1.01","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"summary":"OSR Holdings entered into an Asset Purchase Agreement on May 27, 2026 to acquire intellectual property assets (the VXM01 patent family, know-how, regulatory filings, and clinical data) from its subsidiary Vaximm for $30 million. This constitutes a material acquisition of assets with a defined purchase price and closing conditions, fitting the ma_activity classification. The transaction is material to investors as it restructures ownership of valuable IP assets and triggers future milestone payment obligations under the related License Agreement.","company_name":"OSR Holdings, Inc.","ticker":"OSRHW","filing_date":"2026-06-02","form":"8-K","submitted_at":null,"items":[{"id":3645,"accession_number":"0001213900-26-064037","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"OSR Holdings entered into an Asset Purchase Agreement on May 27, 2026 to acquire intellectual property assets (the VXM01 patent family, know-how, regulatory filings, and clinical data) from its subsidiary Vaximm for $30 million. This constitutes a material acquisition of assets with a defined purchase price and closing conditions, fitting the ma_activity classification. The transaction is material to investors as it restructures ownership of valuable IP assets and triggers future milestone payment obligations under the related License Agreement.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-03T02:37:39.752446+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":3645,"accession_number":"0001213900-26-064037","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"OSR Holdings entered into an Asset Purchase Agreement on May 27, 2026 to acquire intellectual property assets (the VXM01 patent family, know-how, regulatory filings, and clinical data) from its subsidiary Vaximm for $30 million. This constitutes a material acquisition of assets with a defined purchase price and closing conditions, fitting the ma_activity classification. The transaction is material to investors as it restructures ownership of valuable IP assets and triggers future milestone payment obligations under the related License Agreement.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-03T02:37:39.752446+00:00","company_name":"OSR Holdings, Inc.","ticker":"OSRHW","filing_date":"2026-06-02"}]}